Key result
Exercise capacity >14 ml/kg/min is linked to ~94% 1-year survival, outperforming patients accepted or rejected for transplant.
Why the study?
Optimal timing of cardiac transplantation in ambulatory patients with severe left ventricular dysfunction is often difficult, and it was unclear whether peak oxygen consumption during maximal exercise testing could identify patients in whom transplantation can be safely deferred.
Does peak exercise oxygen consumption (VO2 > 14 ml/kg/min) identify ambulatory patients with severe left ventricular dysfunction in whom cardiac transplantation can be safely deferred with preserved 1- and 2-year survival?
Cohort (n=114)
Does peak exercise oxygen consumption (VO2 > 14 ml/kg/min) identify ambulatory patients with severe left ventricular dysfunction in whom cardiac transplantation can be safely deferred with preserved 1- and 2-year survival?
Demonstrates that cardiac transplantation can be safely deferred in ambulatory patients with severe left ventricular dysfunction who achieve a peak exercise VO2 greater than 14 ml/kg/min, as their 1- and 2-year survival rates (94% and 84%) match post-transplant survival.
Answers are grounded in this paper and cite their sources.
VO2 >14 ml/kg/min was associated with superior survival in advanced HF; confirms prognostic value but leaves open transplant deferral without randomized data.
BACKGROUND: Optimal timing of cardiac transplantation in ambulatory patients with severe left ventricular dysfunction is often difficult. To determine whether measurement of peak oxygen consumption (VO2) during maximal exercise testing can be used to identify patients in whom transplantation can be safely deferred, we prospectively performed exercise testing on all ambulatory patients referred for transplant between October 1986 and December 1989. METHODS AND RESULTS: Patients were assigned into one of three groups on the basis of exercise data: Group 1 (n = 35) comprised patients accepted for transplant (VO2 less than or equal to 14 ml/kg/min); group 2 (n = 52) comprised patients considered too well for transplant (VO2 greater than 14 ml/kg/min); and group 3 (n = 27) comprised patients with low VO2 rejected for transplant due to noncardiac problems. All three groups were comparable in New York Heart Association functional class, ejection fraction, and cardiac index (p = NS). Pulmonary capillary wedge pressure was significantly lower in group 2 than in either group 1 or 3 (p less than 0.05), although there was wide overlap. Patients with preserved exercise capacity (group 2) had cumulative 1- and 2-year survival rates of 94% and 84%, which are equal to survival levels after transplantation. In contrast, patients rejected for transplant (group 3) had survival rates of only 47% at 1 year and 32% at 2 years, whereas patients awaiting transplantation (group 1) had a survival rate of 70% at 1 year (both p less than 0.005 versus patients with VO2 greater than 14 ml/kg/min). All deaths in group 2 were sudden. By univariate and multivariate analyses, peak VO2 was the best predictor of survival, with only pulmonary capillary wedge pressure providing additional prognostic information. CONCLUSIONS: These data suggest that cardiac transplantation can be safely deferred in ambulatory patients with severe left ventricular dysfunction and peak exercise VO2 of more than 14 ml/min/kg.
No takes yet. Share an insight, caveat, or question.
Mancini et al. (1991) conducted a cohort in Severe left ventricular dysfunction / heart failure referred for cardiac transplantation (n=114). Peak exercise oxygen consumption (VO2) >14 ml/kg/min (transplantation deferred) vs. Peak exercise VO2 <=14 ml/kg/min (accepted for transplant or rejected due to noncardiac problems) was evaluated on 1-year cumulative survival rate (p=<0.005). Peak exercise VO2 >14 ml/kg/min predicted superior 1-year survival compared to VO2 <=14 ml/kg/min awaiting or rejected for transplant.
Synapse has enriched 10 related papers. Consider them for comparative context: